Triamcinolone, vitamin c (Dermotab)
Triamcinolone, vitamin c
Bayer (Pty) Ltd (Animal Health Division)
Every registration of this product has been cancelled.
Registration
- Applicant
- Bayer (Pty) Ltd (Animal Health Division)
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dermotab EACH TABLET CONTAINS TRIAMCINOLONE A 0,5 mg VITAMIN C A 6,25 mg | Not listed | 83/850 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Vitamin c
- in preparations thereof for injection; (S0)
- except in oral preparations or mixtures containing more than 1000 mg of Vitamin C per recommended daily dose alone or in combination with other active pharmaceutical ingredients. (S1)
Consolidated Schedules 06 July 2026, lines 4435 to 4440
S2: Triamcinolone
- when intended for application to oral lesions.
Consolidated Schedules 06 July 2026, line 2737
S1: Vitamin c
- in oral preparations or mixtures containing more than 1000 mg of Vitamin C per recommended daily dose alone or in combination with other active pharmaceutical ingredients; (S0)
- except in preparations thereof for injection. (S3)
Consolidated Schedules 06 July 2026, lines 1184 to 1189
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.